Similar articles for PMID: 25649308

Year	Number of Results
1988	1
1996	1
2003	1
2005	2
2006	1
2007	1
2008	2
2009	3
2010	3
2011	5
2012	16
2013	13
2014	37
2015	52
2016	42
2017	56
2018	53
2019	64
2020	72
2021	83
2022	47
2023	15
2024	0

1

The promise of ketamine for treatment-resistant depression: current evidence and future directions.

DeWilde KE, Levitch CF, Murrough JW, Mathew SJ, Iosifescu DV. DeWilde KE, et al. Ann N Y Acad Sci. 2015 May;1345(1):47-58. doi: 10.1111/nyas.12646. Epub 2015 Feb 3. Ann N Y Acad Sci. 2015. PMID: 25649308 Free PMC article. Review.

2

Intravenous ketamine for treatment-resistant major depressive disorder.

Covvey JR, Crawford AN, Lowe DK. Covvey JR, et al. Ann Pharmacother. 2012 Jan;46(1):117-23. doi: 10.1345/aph.1Q371. Epub 2011 Dec 20. Ann Pharmacother. 2012. PMID: 22190250 Review.

3

Ketamine for Treatment-Resistant Depression: a New Advocate.

Pérez-Esparza R. Pérez-Esparza R. Rev Invest Clin. 2018;70(2):65-7. doi: 10.24875/RIC.18002501. Rev Invest Clin. 2018. PMID: 29718013 Free article.

4

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.

Naughton M, Clarke G, O'Leary OF, Cryan JF, Dinan TG. Naughton M, et al. J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10. J Affect Disord. 2014. PMID: 24388038 Review.

5

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.

Lally N, Nugent AC, Luckenbaugh DA, Niciu MJ, Roiser JP, Zarate CA Jr. Lally N, et al. J Psychopharmacol. 2015 May;29(5):596-607. doi: 10.1177/0269881114568041. Epub 2015 Feb 17. J Psychopharmacol. 2015. PMID: 25691504 Free PMC article. Clinical Trial.

6

Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.

Murrough JW, Burdick KE, Levitch CF, Perez AM, Brallier JW, Chang LC, Foulkes A, Charney DS, Mathew SJ, Iosifescu DV. Murrough JW, et al. Neuropsychopharmacology. 2015 Mar 13;40(5):1084-90. doi: 10.1038/npp.2014.298. Neuropsychopharmacology. 2015. PMID: 25374095 Free PMC article. Clinical Trial.

7

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Slonena EE, Vande Voort JL, Brutsche NE, Zarate CA Jr. Ionescu DF, et al. J Clin Psychiatry. 2014 Sep;75(9):e932-8. doi: 10.4088/JCP.14m09049. J Clin Psychiatry. 2014. PMID: 25295436 Clinical Trial.

8

[Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression].

Gosek P, Chojnacka M, Bieńkowski P, Swiecicki Ł. Gosek P, et al. Psychiatr Pol. 2012 Mar-Apr;46(2):283-94. Psychiatr Pol. 2012. PMID: 23214398 Review. Polish.

9

Ketamine for treatment-resistant unipolar depression: current evidence.

Mathew SJ, Shah A, Lapidus K, Clark C, Jarun N, Ostermeyer B, Murrough JW. Mathew SJ, et al. CNS Drugs. 2012 Mar 1;26(3):189-204. doi: 10.2165/11599770-000000000-00000. CNS Drugs. 2012. PMID: 22303887 Free PMC article. Review.

10

[Ketamine's antidepressant effect: focus on ketamine mechanisms of action].

De Maricourt P, Jay T, Goncalvès P, Lôo H, Gaillard R. De Maricourt P, et al. Encephale. 2014 Feb;40(1):48-55. doi: 10.1016/j.encep.2013.09.002. Epub 2014 Jan 13. Encephale. 2014. PMID: 24434007 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

482 results

Results by year